BioMarck Pharmaceuticals' Series C Round

BioMarck Pharmaceuticals raised a round of funding on September 17, 2009. Investors include National Institutes of Health.

BioMarck Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of …

Articles about BioMarck Pharmaceuticals' Series C Round: